243 related articles for article (PubMed ID: 38183473)
1. Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma.
Jinato T; Anuntakarun S; Satthawiwat N; Chuaypen N; Tangkijvanich P
Appl Microbiol Biotechnol; 2024 Dec; 108(1):34. PubMed ID: 38183473
[TBL] [Abstract][Full Text] [Related]
2. Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma.
Liu Q; Li F; Zhuang Y; Xu J; Wang J; Mao X; Zhang Y; Liu X
Gut Pathog; 2019; 11():1. PubMed ID: 30675188
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Zeng Y; Chen S; Fu Y; Wu W; Chen T; Chen J; Yang B; Ou Q
J Viral Hepat; 2020 Feb; 27(2):143-155. PubMed ID: 31600845
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X
Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112
[TBL] [Abstract][Full Text] [Related]
5. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
[TBL] [Abstract][Full Text] [Related]
6. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma.
Zheng R; Wang G; Pang Z; Ran N; Gu Y; Guan X; Yuan Y; Zuo X; Pan H; Zheng J; Wang F
Cancer Med; 2020 Jun; 9(12):4232-4250. PubMed ID: 32281295
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
Huang H; Ren Z; Gao X; Hu X; Zhou Y; Jiang J; Lu H; Yin S; Ji J; Zhou L; Zheng S
Genome Med; 2020 Nov; 12(1):102. PubMed ID: 33225985
[TBL] [Abstract][Full Text] [Related]
8. Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma.
Zhang W; Xu X; Cai L; Cai X
Sci Rep; 2023 May; 13(1):7797. PubMed ID: 37179446
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma.
Tang Y; Zhou H; Xiang Y; Cui F
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e167-e175. PubMed ID: 33208683
[TBL] [Abstract][Full Text] [Related]
10. A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma.
Yang J; He Q; Lu F; Chen K; Ni Z; Wang H; Zhou C; Zhang Y; Chen B; Bo Z; Li J; Yu H; Wang Y; Chen G
Gut Microbes; 2023; 15(1):2201159. PubMed ID: 37089022
[TBL] [Abstract][Full Text] [Related]
11. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer.
Deng T; Li J; He B; Chen B; Liu F; Chen Z; Zheng J; Shi Z; Zhang T; Deng L; Yu H; Yang J; Wu L; Shan Y; Yu Z; Chen X; Wang Y; Chen G
Hepatol Int; 2022 Feb; 16(1):99-111. PubMed ID: 35064546
[TBL] [Abstract][Full Text] [Related]
13. The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma.
Huang JH; Wang J; Chai XQ; Li ZC; Jiang YH; Li J; Liu X; Fan J; Cai JB; Liu F
Microbiol Spectr; 2022 Oct; 10(5):e0098322. PubMed ID: 36173308
[TBL] [Abstract][Full Text] [Related]
14. A Predictive Model Based on the Gut Microbiota Improves the Diagnostic Effect in Patients With Cholangiocarcinoma.
Zhang T; Zhang S; Jin C; Lin Z; Deng T; Xie X; Deng L; Li X; Ma J; Ding X; Liu Y; Shan Y; Yu Z; Wang Y; Chen G; Li J
Front Cell Infect Microbiol; 2021; 11():751795. PubMed ID: 34888258
[TBL] [Abstract][Full Text] [Related]
15. Altered Gut Microbiota Composition and Its Potential Association in Patients with Advanced Hepatocellular Carcinoma.
Huo R; Chen Y; Li J; Xu Q; Guo J; Xu H; You Y; Zheng C; Chen Y
Curr Oncol; 2023 Feb; 30(2):1818-1830. PubMed ID: 36826102
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma.
Ren Z; Li A; Jiang J; Zhou L; Yu Z; Lu H; Xie H; Chen X; Shao L; Zhang R; Xu S; Zhang H; Cui G; Chen X; Sun R; Wen H; Lerut JP; Kan Q; Li L; Zheng S
Gut; 2019 Jun; 68(6):1014-1023. PubMed ID: 30045880
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Lactic Acid Bacteria Anti-Hepatitis B Virus (HBV) Effect and Modulation of the Intestinal Microbiota in Fecal Cultures from HBV-Associated Hepatocellular Carcinoma Patients.
Yang J; Gao H; Zhang T; Fan Y; Wu Y; Zhao X; Li Y; Wu L; Zhao H; Yang L; Zhong H; Li L; Xie X; Wu Q
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474727
[TBL] [Abstract][Full Text] [Related]
18. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites.
Zhang X; Coker OO; Chu ES; Fu K; Lau HCH; Wang YX; Chan AWH; Wei H; Yang X; Sung JJY; Yu J
Gut; 2021 Apr; 70(4):761-774. PubMed ID: 32694178
[TBL] [Abstract][Full Text] [Related]
19. Dysbiosis of the gut microbiota as a susceptibility factor for Kawasaki disease.
Teramoto Y; Akagawa S; Hori SI; Tsuji S; Higasa K; Kaneko K
Front Immunol; 2023; 14():1268453. PubMed ID: 38022552
[TBL] [Abstract][Full Text] [Related]
20. Dysbiosis of gut microbiota in patients with esophageal cancer.
Deng Y; Tang D; Hou P; Shen W; Li H; Wang T; Liu R
Microb Pathog; 2021 Jan; 150():104709. PubMed ID: 33378710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
